Global mRNA Vaccine And Therapeutics Market Growth (Status and Outlook) 2025-2031
According to this study, the global mRNA Vaccine And Therapeutics market size will reach US$ 55640 million by 2031.
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “mRNA Vaccine And Therapeutics Industry Forecast” looks at past sales and reviews total world mRNA Vaccine And Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected mRNA Vaccine And Therapeutics sales for 2025 through 2031. With mRNA Vaccine And Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA Vaccine And Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global mRNA Vaccine And Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on mRNA Vaccine And Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global mRNA Vaccine And Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA Vaccine And Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA Vaccine And Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Vaccine And Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “mRNA Vaccine And Therapeutics Industry Forecast” looks at past sales and reviews total world mRNA Vaccine And Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected mRNA Vaccine And Therapeutics sales for 2025 through 2031. With mRNA Vaccine And Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA Vaccine And Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global mRNA Vaccine And Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on mRNA Vaccine And Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global mRNA Vaccine And Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA Vaccine And Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA Vaccine And Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Vaccine And Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Infectious Disease
- Cancer
- Others
- Hospital
- Research Institual
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Argos Therapeutics
- BioNTech
- CureVac
- eTheRNA
- Ethris
- In-Cell-Art
- Moderna Therapeutics
- Sangamo Therapeutics
- Tiba Biotechnology
- Translate Bio
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global mRNA Vaccine And Therapeutics Market Size (2020-2031)
2.1.2 mRNA Vaccine And Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for mRNA Vaccine And Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 mRNA Vaccine And Therapeutics Segment by Type
2.2.1 Infectious Disease
2.2.2 Cancer
2.2.3 Others
2.3 mRNA Vaccine And Therapeutics Market Size by Type
2.3.1 mRNA Vaccine And Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global mRNA Vaccine And Therapeutics Market Size Market Share by Type (2020-2025)
2.4 mRNA Vaccine And Therapeutics Segment by Application
2.4.1 Hospital
2.4.2 Research Institual
2.5 mRNA Vaccine And Therapeutics Market Size by Application
2.5.1 mRNA Vaccine And Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global mRNA Vaccine And Therapeutics Market Size Market Share by Application (2020-2025)
3 MRNA VACCINE AND THERAPEUTICS MARKET SIZE BY PLAYER
3.1 mRNA Vaccine And Therapeutics Market Size Market Share by Player
3.1.1 Global mRNA Vaccine And Therapeutics Revenue by Player (2020-2025)
3.1.2 Global mRNA Vaccine And Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global mRNA Vaccine And Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MRNA VACCINE AND THERAPEUTICS BY REGION
4.1 mRNA Vaccine And Therapeutics Market Size by Region (2020-2025)
4.2 Global mRNA Vaccine And Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas mRNA Vaccine And Therapeutics Market Size Growth (2020-2025)
4.4 APAC mRNA Vaccine And Therapeutics Market Size Growth (2020-2025)
4.5 Europe mRNA Vaccine And Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa mRNA Vaccine And Therapeutics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas mRNA Vaccine And Therapeutics Market Size by Country (2020-2025)
5.2 Americas mRNA Vaccine And Therapeutics Market Size by Type (2020-2025)
5.3 Americas mRNA Vaccine And Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Vaccine And Therapeutics Market Size by Region (2020-2025)
6.2 APAC mRNA Vaccine And Therapeutics Market Size by Type (2020-2025)
6.3 APAC mRNA Vaccine And Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe mRNA Vaccine And Therapeutics Market Size by Country (2020-2025)
7.2 Europe mRNA Vaccine And Therapeutics Market Size by Type (2020-2025)
7.3 Europe mRNA Vaccine And Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa mRNA Vaccine And Therapeutics by Region (2020-2025)
8.2 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MRNA VACCINE AND THERAPEUTICS MARKET FORECAST
10.1 Global mRNA Vaccine And Therapeutics Forecast by Region (2026-2031)
10.1.1 Global mRNA Vaccine And Therapeutics Forecast by Region (2026-2031)
10.1.2 Americas mRNA Vaccine And Therapeutics Forecast
10.1.3 APAC mRNA Vaccine And Therapeutics Forecast
10.1.4 Europe mRNA Vaccine And Therapeutics Forecast
10.1.5 Middle East & Africa mRNA Vaccine And Therapeutics Forecast
10.2 Americas mRNA Vaccine And Therapeutics Forecast by Country (2026-2031)
10.2.1 United States Market mRNA Vaccine And Therapeutics Forecast
10.2.2 Canada Market mRNA Vaccine And Therapeutics Forecast
10.2.3 Mexico Market mRNA Vaccine And Therapeutics Forecast
10.2.4 Brazil Market mRNA Vaccine And Therapeutics Forecast
10.3 APAC mRNA Vaccine And Therapeutics Forecast by Region (2026-2031)
10.3.1 China mRNA Vaccine And Therapeutics Market Forecast
10.3.2 Japan Market mRNA Vaccine And Therapeutics Forecast
10.3.3 Korea Market mRNA Vaccine And Therapeutics Forecast
10.3.4 Southeast Asia Market mRNA Vaccine And Therapeutics Forecast
10.3.5 India Market mRNA Vaccine And Therapeutics Forecast
10.3.6 Australia Market mRNA Vaccine And Therapeutics Forecast
10.4 Europe mRNA Vaccine And Therapeutics Forecast by Country (2026-2031)
10.4.1 Germany Market mRNA Vaccine And Therapeutics Forecast
10.4.2 France Market mRNA Vaccine And Therapeutics Forecast
10.4.3 UK Market mRNA Vaccine And Therapeutics Forecast
10.4.4 Italy Market mRNA Vaccine And Therapeutics Forecast
10.4.5 Russia Market mRNA Vaccine And Therapeutics Forecast
10.5 Middle East & Africa mRNA Vaccine And Therapeutics Forecast by Region (2026-2031)
10.5.1 Egypt Market mRNA Vaccine And Therapeutics Forecast
10.5.2 South Africa Market mRNA Vaccine And Therapeutics Forecast
10.5.3 Israel Market mRNA Vaccine And Therapeutics Forecast
10.5.4 Turkey Market mRNA Vaccine And Therapeutics Forecast
10.6 Global mRNA Vaccine And Therapeutics Forecast by Type (2026-2031)
10.7 Global mRNA Vaccine And Therapeutics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market mRNA Vaccine And Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Argos Therapeutics
11.1.1 Argos Therapeutics Company Information
11.1.2 Argos Therapeutics mRNA Vaccine And Therapeutics Product Offered
11.1.3 Argos Therapeutics mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Argos Therapeutics Main Business Overview
11.1.5 Argos Therapeutics Latest Developments
11.2 BioNTech
11.2.1 BioNTech Company Information
11.2.2 BioNTech mRNA Vaccine And Therapeutics Product Offered
11.2.3 BioNTech mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 BioNTech Main Business Overview
11.2.5 BioNTech Latest Developments
11.3 CureVac
11.3.1 CureVac Company Information
11.3.2 CureVac mRNA Vaccine And Therapeutics Product Offered
11.3.3 CureVac mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 CureVac Main Business Overview
11.3.5 CureVac Latest Developments
11.4 eTheRNA
11.4.1 eTheRNA Company Information
11.4.2 eTheRNA mRNA Vaccine And Therapeutics Product Offered
11.4.3 eTheRNA mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 eTheRNA Main Business Overview
11.4.5 eTheRNA Latest Developments
11.5 Ethris
11.5.1 Ethris Company Information
11.5.2 Ethris mRNA Vaccine And Therapeutics Product Offered
11.5.3 Ethris mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Ethris Main Business Overview
11.5.5 Ethris Latest Developments
11.6 In-Cell-Art
11.6.1 In-Cell-Art Company Information
11.6.2 In-Cell-Art mRNA Vaccine And Therapeutics Product Offered
11.6.3 In-Cell-Art mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 In-Cell-Art Main Business Overview
11.6.5 In-Cell-Art Latest Developments
11.7 Moderna Therapeutics
11.7.1 Moderna Therapeutics Company Information
11.7.2 Moderna Therapeutics mRNA Vaccine And Therapeutics Product Offered
11.7.3 Moderna Therapeutics mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Moderna Therapeutics Main Business Overview
11.7.5 Moderna Therapeutics Latest Developments
11.8 Sangamo Therapeutics
11.8.1 Sangamo Therapeutics Company Information
11.8.2 Sangamo Therapeutics mRNA Vaccine And Therapeutics Product Offered
11.8.3 Sangamo Therapeutics mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Sangamo Therapeutics Main Business Overview
11.8.5 Sangamo Therapeutics Latest Developments
11.9 Tiba Biotechnology
11.9.1 Tiba Biotechnology Company Information
11.9.2 Tiba Biotechnology mRNA Vaccine And Therapeutics Product Offered
11.9.3 Tiba Biotechnology mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Tiba Biotechnology Main Business Overview
11.9.5 Tiba Biotechnology Latest Developments
11.10 Translate Bio
11.10.1 Translate Bio Company Information
11.10.2 Translate Bio mRNA Vaccine And Therapeutics Product Offered
11.10.3 Translate Bio mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Translate Bio Main Business Overview
11.10.5 Translate Bio Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global mRNA Vaccine And Therapeutics Market Size (2020-2031)
2.1.2 mRNA Vaccine And Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for mRNA Vaccine And Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 mRNA Vaccine And Therapeutics Segment by Type
2.2.1 Infectious Disease
2.2.2 Cancer
2.2.3 Others
2.3 mRNA Vaccine And Therapeutics Market Size by Type
2.3.1 mRNA Vaccine And Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global mRNA Vaccine And Therapeutics Market Size Market Share by Type (2020-2025)
2.4 mRNA Vaccine And Therapeutics Segment by Application
2.4.1 Hospital
2.4.2 Research Institual
2.5 mRNA Vaccine And Therapeutics Market Size by Application
2.5.1 mRNA Vaccine And Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global mRNA Vaccine And Therapeutics Market Size Market Share by Application (2020-2025)
3 MRNA VACCINE AND THERAPEUTICS MARKET SIZE BY PLAYER
3.1 mRNA Vaccine And Therapeutics Market Size Market Share by Player
3.1.1 Global mRNA Vaccine And Therapeutics Revenue by Player (2020-2025)
3.1.2 Global mRNA Vaccine And Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global mRNA Vaccine And Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MRNA VACCINE AND THERAPEUTICS BY REGION
4.1 mRNA Vaccine And Therapeutics Market Size by Region (2020-2025)
4.2 Global mRNA Vaccine And Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas mRNA Vaccine And Therapeutics Market Size Growth (2020-2025)
4.4 APAC mRNA Vaccine And Therapeutics Market Size Growth (2020-2025)
4.5 Europe mRNA Vaccine And Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa mRNA Vaccine And Therapeutics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas mRNA Vaccine And Therapeutics Market Size by Country (2020-2025)
5.2 Americas mRNA Vaccine And Therapeutics Market Size by Type (2020-2025)
5.3 Americas mRNA Vaccine And Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Vaccine And Therapeutics Market Size by Region (2020-2025)
6.2 APAC mRNA Vaccine And Therapeutics Market Size by Type (2020-2025)
6.3 APAC mRNA Vaccine And Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe mRNA Vaccine And Therapeutics Market Size by Country (2020-2025)
7.2 Europe mRNA Vaccine And Therapeutics Market Size by Type (2020-2025)
7.3 Europe mRNA Vaccine And Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa mRNA Vaccine And Therapeutics by Region (2020-2025)
8.2 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MRNA VACCINE AND THERAPEUTICS MARKET FORECAST
10.1 Global mRNA Vaccine And Therapeutics Forecast by Region (2026-2031)
10.1.1 Global mRNA Vaccine And Therapeutics Forecast by Region (2026-2031)
10.1.2 Americas mRNA Vaccine And Therapeutics Forecast
10.1.3 APAC mRNA Vaccine And Therapeutics Forecast
10.1.4 Europe mRNA Vaccine And Therapeutics Forecast
10.1.5 Middle East & Africa mRNA Vaccine And Therapeutics Forecast
10.2 Americas mRNA Vaccine And Therapeutics Forecast by Country (2026-2031)
10.2.1 United States Market mRNA Vaccine And Therapeutics Forecast
10.2.2 Canada Market mRNA Vaccine And Therapeutics Forecast
10.2.3 Mexico Market mRNA Vaccine And Therapeutics Forecast
10.2.4 Brazil Market mRNA Vaccine And Therapeutics Forecast
10.3 APAC mRNA Vaccine And Therapeutics Forecast by Region (2026-2031)
10.3.1 China mRNA Vaccine And Therapeutics Market Forecast
10.3.2 Japan Market mRNA Vaccine And Therapeutics Forecast
10.3.3 Korea Market mRNA Vaccine And Therapeutics Forecast
10.3.4 Southeast Asia Market mRNA Vaccine And Therapeutics Forecast
10.3.5 India Market mRNA Vaccine And Therapeutics Forecast
10.3.6 Australia Market mRNA Vaccine And Therapeutics Forecast
10.4 Europe mRNA Vaccine And Therapeutics Forecast by Country (2026-2031)
10.4.1 Germany Market mRNA Vaccine And Therapeutics Forecast
10.4.2 France Market mRNA Vaccine And Therapeutics Forecast
10.4.3 UK Market mRNA Vaccine And Therapeutics Forecast
10.4.4 Italy Market mRNA Vaccine And Therapeutics Forecast
10.4.5 Russia Market mRNA Vaccine And Therapeutics Forecast
10.5 Middle East & Africa mRNA Vaccine And Therapeutics Forecast by Region (2026-2031)
10.5.1 Egypt Market mRNA Vaccine And Therapeutics Forecast
10.5.2 South Africa Market mRNA Vaccine And Therapeutics Forecast
10.5.3 Israel Market mRNA Vaccine And Therapeutics Forecast
10.5.4 Turkey Market mRNA Vaccine And Therapeutics Forecast
10.6 Global mRNA Vaccine And Therapeutics Forecast by Type (2026-2031)
10.7 Global mRNA Vaccine And Therapeutics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market mRNA Vaccine And Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Argos Therapeutics
11.1.1 Argos Therapeutics Company Information
11.1.2 Argos Therapeutics mRNA Vaccine And Therapeutics Product Offered
11.1.3 Argos Therapeutics mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Argos Therapeutics Main Business Overview
11.1.5 Argos Therapeutics Latest Developments
11.2 BioNTech
11.2.1 BioNTech Company Information
11.2.2 BioNTech mRNA Vaccine And Therapeutics Product Offered
11.2.3 BioNTech mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 BioNTech Main Business Overview
11.2.5 BioNTech Latest Developments
11.3 CureVac
11.3.1 CureVac Company Information
11.3.2 CureVac mRNA Vaccine And Therapeutics Product Offered
11.3.3 CureVac mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 CureVac Main Business Overview
11.3.5 CureVac Latest Developments
11.4 eTheRNA
11.4.1 eTheRNA Company Information
11.4.2 eTheRNA mRNA Vaccine And Therapeutics Product Offered
11.4.3 eTheRNA mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 eTheRNA Main Business Overview
11.4.5 eTheRNA Latest Developments
11.5 Ethris
11.5.1 Ethris Company Information
11.5.2 Ethris mRNA Vaccine And Therapeutics Product Offered
11.5.3 Ethris mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Ethris Main Business Overview
11.5.5 Ethris Latest Developments
11.6 In-Cell-Art
11.6.1 In-Cell-Art Company Information
11.6.2 In-Cell-Art mRNA Vaccine And Therapeutics Product Offered
11.6.3 In-Cell-Art mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 In-Cell-Art Main Business Overview
11.6.5 In-Cell-Art Latest Developments
11.7 Moderna Therapeutics
11.7.1 Moderna Therapeutics Company Information
11.7.2 Moderna Therapeutics mRNA Vaccine And Therapeutics Product Offered
11.7.3 Moderna Therapeutics mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Moderna Therapeutics Main Business Overview
11.7.5 Moderna Therapeutics Latest Developments
11.8 Sangamo Therapeutics
11.8.1 Sangamo Therapeutics Company Information
11.8.2 Sangamo Therapeutics mRNA Vaccine And Therapeutics Product Offered
11.8.3 Sangamo Therapeutics mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Sangamo Therapeutics Main Business Overview
11.8.5 Sangamo Therapeutics Latest Developments
11.9 Tiba Biotechnology
11.9.1 Tiba Biotechnology Company Information
11.9.2 Tiba Biotechnology mRNA Vaccine And Therapeutics Product Offered
11.9.3 Tiba Biotechnology mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Tiba Biotechnology Main Business Overview
11.9.5 Tiba Biotechnology Latest Developments
11.10 Translate Bio
11.10.1 Translate Bio Company Information
11.10.2 Translate Bio mRNA Vaccine And Therapeutics Product Offered
11.10.3 Translate Bio mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Translate Bio Main Business Overview
11.10.5 Translate Bio Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. mRNA Vaccine And Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. mRNA Vaccine And Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Infectious Disease
Table 4. Major Players of Cancer
Table 5. Major Players of Others
Table 6. mRNA Vaccine And Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global mRNA Vaccine And Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 8. Global mRNA Vaccine And Therapeutics Market Size Market Share by Type (2020-2025)
Table 9. mRNA Vaccine And Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global mRNA Vaccine And Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 11. Global mRNA Vaccine And Therapeutics Market Size Market Share by Application (2020-2025)
Table 12. Global mRNA Vaccine And Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 13. Global mRNA Vaccine And Therapeutics Revenue Market Share by Player (2020-2025)
Table 14. mRNA Vaccine And Therapeutics Key Players Head office and Products Offered
Table 15. mRNA Vaccine And Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global mRNA Vaccine And Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 19. Global mRNA Vaccine And Therapeutics Market Size Market Share by Region (2020-2025)
Table 20. Global mRNA Vaccine And Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global mRNA Vaccine And Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas mRNA Vaccine And Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas mRNA Vaccine And Therapeutics Market Size Market Share by Country (2020-2025)
Table 24. Americas mRNA Vaccine And Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas mRNA Vaccine And Therapeutics Market Size Market Share by Type (2020-2025)
Table 26. Americas mRNA Vaccine And Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas mRNA Vaccine And Therapeutics Market Size Market Share by Application (2020-2025)
Table 28. APAC mRNA Vaccine And Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC mRNA Vaccine And Therapeutics Market Size Market Share by Region (2020-2025)
Table 30. APAC mRNA Vaccine And Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC mRNA Vaccine And Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe mRNA Vaccine And Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe mRNA Vaccine And Therapeutics Market Size Market Share by Country (2020-2025)
Table 34. Europe mRNA Vaccine And Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe mRNA Vaccine And Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of mRNA Vaccine And Therapeutics
Table 40. Key Market Challenges & Risks of mRNA Vaccine And Therapeutics
Table 41. Key Industry Trends of mRNA Vaccine And Therapeutics
Table 42. Global mRNA Vaccine And Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global mRNA Vaccine And Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global mRNA Vaccine And Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global mRNA Vaccine And Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Argos Therapeutics Details, Company Type, mRNA Vaccine And Therapeutics Area Served and Its Competitors
Table 47. Argos Therapeutics mRNA Vaccine And Therapeutics Product Offered
Table 48. Argos Therapeutics mRNA Vaccine And Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Argos Therapeutics Main Business
Table 50. Argos Therapeutics Latest Developments
Table 51. BioNTech Details, Company Type, mRNA Vaccine And Therapeutics Area Served and Its Competitors
Table 52. BioNTech mRNA Vaccine And Therapeutics Product Offered
Table 53. BioNTech mRNA Vaccine And Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. BioNTech Main Business
Table 55. BioNTech Latest Developments
Table 56. CureVac Details, Company Type, mRNA Vaccine And Therapeutics Area Served and Its Competitors
Table 57. CureVac mRNA Vaccine And Therapeutics Product Offered
Table 58. CureVac mRNA Vaccine And Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. CureVac Main Business
Table 60. CureVac Latest Developments
Table 61. eTheRNA Details, Company Type, mRNA Vaccine And Therapeutics Area Served and Its Competitors
Table 62. eTheRNA mRNA Vaccine And Therapeutics Product Offered
Table 63. eTheRNA mRNA Vaccine And Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. eTheRNA Main Business
Table 65. eTheRNA Latest Developments
Table 66. Ethris Details, Company Type, mRNA Vaccine And Therapeutics Area Served and Its Competitors
Table 67. Ethris mRNA Vaccine And Therapeutics Product Offered
Table 68. Ethris mRNA Vaccine And Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Ethris Main Business
Table 70. Ethris Latest Developments
Table 71. In-Cell-Art Details, Company Type, mRNA Vaccine And Therapeutics Area Served and Its Competitors
Table 72. In-Cell-Art mRNA Vaccine And Therapeutics Product Offered
Table 73. In-Cell-Art mRNA Vaccine And Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. In-Cell-Art Main Business
Table 75. In-Cell-Art Latest Developments
Table 76. Moderna Therapeutics Details, Company Type, mRNA Vaccine And Therapeutics Area Served and Its Competitors
Table 77. Moderna Therapeutics mRNA Vaccine And Therapeutics Product Offered
Table 78. Moderna Therapeutics mRNA Vaccine And Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Moderna Therapeutics Main Business
Table 80. Moderna Therapeutics Latest Developments
Table 81. Sangamo Therapeutics Details, Company Type, mRNA Vaccine And Therapeutics Area Served and Its Competitors
Table 82. Sangamo Therapeutics mRNA Vaccine And Therapeutics Product Offered
Table 83. Sangamo Therapeutics mRNA Vaccine And Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Sangamo Therapeutics Main Business
Table 85. Sangamo Therapeutics Latest Developments
Table 86. Tiba Biotechnology Details, Company Type, mRNA Vaccine And Therapeutics Area Served and Its Competitors
Table 87. Tiba Biotechnology mRNA Vaccine And Therapeutics Product Offered
Table 88. Tiba Biotechnology mRNA Vaccine And Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Tiba Biotechnology Main Business
Table 90. Tiba Biotechnology Latest Developments
Table 91. Translate Bio Details, Company Type, mRNA Vaccine And Therapeutics Area Served and Its Competitors
Table 92. Translate Bio mRNA Vaccine And Therapeutics Product Offered
Table 93. Translate Bio mRNA Vaccine And Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Translate Bio Main Business
Table 95. Translate Bio Latest Developments
Table 1. mRNA Vaccine And Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. mRNA Vaccine And Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Infectious Disease
Table 4. Major Players of Cancer
Table 5. Major Players of Others
Table 6. mRNA Vaccine And Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global mRNA Vaccine And Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 8. Global mRNA Vaccine And Therapeutics Market Size Market Share by Type (2020-2025)
Table 9. mRNA Vaccine And Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global mRNA Vaccine And Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 11. Global mRNA Vaccine And Therapeutics Market Size Market Share by Application (2020-2025)
Table 12. Global mRNA Vaccine And Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 13. Global mRNA Vaccine And Therapeutics Revenue Market Share by Player (2020-2025)
Table 14. mRNA Vaccine And Therapeutics Key Players Head office and Products Offered
Table 15. mRNA Vaccine And Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global mRNA Vaccine And Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 19. Global mRNA Vaccine And Therapeutics Market Size Market Share by Region (2020-2025)
Table 20. Global mRNA Vaccine And Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global mRNA Vaccine And Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas mRNA Vaccine And Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas mRNA Vaccine And Therapeutics Market Size Market Share by Country (2020-2025)
Table 24. Americas mRNA Vaccine And Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas mRNA Vaccine And Therapeutics Market Size Market Share by Type (2020-2025)
Table 26. Americas mRNA Vaccine And Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas mRNA Vaccine And Therapeutics Market Size Market Share by Application (2020-2025)
Table 28. APAC mRNA Vaccine And Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC mRNA Vaccine And Therapeutics Market Size Market Share by Region (2020-2025)
Table 30. APAC mRNA Vaccine And Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC mRNA Vaccine And Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe mRNA Vaccine And Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe mRNA Vaccine And Therapeutics Market Size Market Share by Country (2020-2025)
Table 34. Europe mRNA Vaccine And Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe mRNA Vaccine And Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of mRNA Vaccine And Therapeutics
Table 40. Key Market Challenges & Risks of mRNA Vaccine And Therapeutics
Table 41. Key Industry Trends of mRNA Vaccine And Therapeutics
Table 42. Global mRNA Vaccine And Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global mRNA Vaccine And Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global mRNA Vaccine And Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global mRNA Vaccine And Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Argos Therapeutics Details, Company Type, mRNA Vaccine And Therapeutics Area Served and Its Competitors
Table 47. Argos Therapeutics mRNA Vaccine And Therapeutics Product Offered
Table 48. Argos Therapeutics mRNA Vaccine And Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Argos Therapeutics Main Business
Table 50. Argos Therapeutics Latest Developments
Table 51. BioNTech Details, Company Type, mRNA Vaccine And Therapeutics Area Served and Its Competitors
Table 52. BioNTech mRNA Vaccine And Therapeutics Product Offered
Table 53. BioNTech mRNA Vaccine And Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. BioNTech Main Business
Table 55. BioNTech Latest Developments
Table 56. CureVac Details, Company Type, mRNA Vaccine And Therapeutics Area Served and Its Competitors
Table 57. CureVac mRNA Vaccine And Therapeutics Product Offered
Table 58. CureVac mRNA Vaccine And Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. CureVac Main Business
Table 60. CureVac Latest Developments
Table 61. eTheRNA Details, Company Type, mRNA Vaccine And Therapeutics Area Served and Its Competitors
Table 62. eTheRNA mRNA Vaccine And Therapeutics Product Offered
Table 63. eTheRNA mRNA Vaccine And Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. eTheRNA Main Business
Table 65. eTheRNA Latest Developments
Table 66. Ethris Details, Company Type, mRNA Vaccine And Therapeutics Area Served and Its Competitors
Table 67. Ethris mRNA Vaccine And Therapeutics Product Offered
Table 68. Ethris mRNA Vaccine And Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Ethris Main Business
Table 70. Ethris Latest Developments
Table 71. In-Cell-Art Details, Company Type, mRNA Vaccine And Therapeutics Area Served and Its Competitors
Table 72. In-Cell-Art mRNA Vaccine And Therapeutics Product Offered
Table 73. In-Cell-Art mRNA Vaccine And Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. In-Cell-Art Main Business
Table 75. In-Cell-Art Latest Developments
Table 76. Moderna Therapeutics Details, Company Type, mRNA Vaccine And Therapeutics Area Served and Its Competitors
Table 77. Moderna Therapeutics mRNA Vaccine And Therapeutics Product Offered
Table 78. Moderna Therapeutics mRNA Vaccine And Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Moderna Therapeutics Main Business
Table 80. Moderna Therapeutics Latest Developments
Table 81. Sangamo Therapeutics Details, Company Type, mRNA Vaccine And Therapeutics Area Served and Its Competitors
Table 82. Sangamo Therapeutics mRNA Vaccine And Therapeutics Product Offered
Table 83. Sangamo Therapeutics mRNA Vaccine And Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Sangamo Therapeutics Main Business
Table 85. Sangamo Therapeutics Latest Developments
Table 86. Tiba Biotechnology Details, Company Type, mRNA Vaccine And Therapeutics Area Served and Its Competitors
Table 87. Tiba Biotechnology mRNA Vaccine And Therapeutics Product Offered
Table 88. Tiba Biotechnology mRNA Vaccine And Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Tiba Biotechnology Main Business
Table 90. Tiba Biotechnology Latest Developments
Table 91. Translate Bio Details, Company Type, mRNA Vaccine And Therapeutics Area Served and Its Competitors
Table 92. Translate Bio mRNA Vaccine And Therapeutics Product Offered
Table 93. Translate Bio mRNA Vaccine And Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Translate Bio Main Business
Table 95. Translate Bio Latest Developments
LIST OF FIGURES
Figure 1. mRNA Vaccine And Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global mRNA Vaccine And Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. mRNA Vaccine And Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. mRNA Vaccine And Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. mRNA Vaccine And Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global mRNA Vaccine And Therapeutics Market Size Market Share by Type in 2024
Figure 10. mRNA Vaccine And Therapeutics in Hospital
Figure 11. Global mRNA Vaccine And Therapeutics Market: Hospital (2020-2025) & ($ millions)
Figure 12. mRNA Vaccine And Therapeutics in Research Institual
Figure 13. Global mRNA Vaccine And Therapeutics Market: Research Institual (2020-2025) & ($ millions)
Figure 14. Global mRNA Vaccine And Therapeutics Market Size Market Share by Application in 2024
Figure 15. Global mRNA Vaccine And Therapeutics Revenue Market Share by Player in 2024
Figure 16. Global mRNA Vaccine And Therapeutics Market Size Market Share by Region (2020-2025)
Figure 17. Americas mRNA Vaccine And Therapeutics Market Size 2020-2025 ($ millions)
Figure 18. APAC mRNA Vaccine And Therapeutics Market Size 2020-2025 ($ millions)
Figure 19. Europe mRNA Vaccine And Therapeutics Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa mRNA Vaccine And Therapeutics Market Size 2020-2025 ($ millions)
Figure 21. Americas mRNA Vaccine And Therapeutics Value Market Share by Country in 2024
Figure 22. United States mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC mRNA Vaccine And Therapeutics Market Size Market Share by Region in 2024
Figure 27. APAC mRNA Vaccine And Therapeutics Market Size Market Share by Type (2020-2025)
Figure 28. APAC mRNA Vaccine And Therapeutics Market Size Market Share by Application (2020-2025)
Figure 29. China mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 33. India mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe mRNA Vaccine And Therapeutics Market Size Market Share by Country in 2024
Figure 36. Europe mRNA Vaccine And Therapeutics Market Size Market Share by Type (2020-2025)
Figure 37. Europe mRNA Vaccine And Therapeutics Market Size Market Share by Application (2020-2025)
Figure 38. Germany mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 39. France mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 40. UK mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa mRNA Vaccine And Therapeutics Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa mRNA Vaccine And Therapeutics Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa mRNA Vaccine And Therapeutics Market Size Market Share by Application (2020-2025)
Figure 46. Egypt mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 52. APAC mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 53. Europe mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 55. United States mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. Canada mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. Mexico mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Brazil mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. China mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Japan mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. Korea mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. India mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Australia mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. Germany mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. France mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. UK mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. Italy mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. Russia mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Egypt mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. South Africa mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Israel mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. Turkey mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Global mRNA Vaccine And Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global mRNA Vaccine And Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 1. mRNA Vaccine And Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global mRNA Vaccine And Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. mRNA Vaccine And Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. mRNA Vaccine And Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. mRNA Vaccine And Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global mRNA Vaccine And Therapeutics Market Size Market Share by Type in 2024
Figure 10. mRNA Vaccine And Therapeutics in Hospital
Figure 11. Global mRNA Vaccine And Therapeutics Market: Hospital (2020-2025) & ($ millions)
Figure 12. mRNA Vaccine And Therapeutics in Research Institual
Figure 13. Global mRNA Vaccine And Therapeutics Market: Research Institual (2020-2025) & ($ millions)
Figure 14. Global mRNA Vaccine And Therapeutics Market Size Market Share by Application in 2024
Figure 15. Global mRNA Vaccine And Therapeutics Revenue Market Share by Player in 2024
Figure 16. Global mRNA Vaccine And Therapeutics Market Size Market Share by Region (2020-2025)
Figure 17. Americas mRNA Vaccine And Therapeutics Market Size 2020-2025 ($ millions)
Figure 18. APAC mRNA Vaccine And Therapeutics Market Size 2020-2025 ($ millions)
Figure 19. Europe mRNA Vaccine And Therapeutics Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa mRNA Vaccine And Therapeutics Market Size 2020-2025 ($ millions)
Figure 21. Americas mRNA Vaccine And Therapeutics Value Market Share by Country in 2024
Figure 22. United States mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC mRNA Vaccine And Therapeutics Market Size Market Share by Region in 2024
Figure 27. APAC mRNA Vaccine And Therapeutics Market Size Market Share by Type (2020-2025)
Figure 28. APAC mRNA Vaccine And Therapeutics Market Size Market Share by Application (2020-2025)
Figure 29. China mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 33. India mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe mRNA Vaccine And Therapeutics Market Size Market Share by Country in 2024
Figure 36. Europe mRNA Vaccine And Therapeutics Market Size Market Share by Type (2020-2025)
Figure 37. Europe mRNA Vaccine And Therapeutics Market Size Market Share by Application (2020-2025)
Figure 38. Germany mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 39. France mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 40. UK mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa mRNA Vaccine And Therapeutics Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa mRNA Vaccine And Therapeutics Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa mRNA Vaccine And Therapeutics Market Size Market Share by Application (2020-2025)
Figure 46. Egypt mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries mRNA Vaccine And Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 52. APAC mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 53. Europe mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 55. United States mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. Canada mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. Mexico mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Brazil mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. China mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Japan mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. Korea mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. India mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Australia mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. Germany mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. France mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. UK mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. Italy mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. Russia mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Egypt mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. South Africa mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Israel mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. Turkey mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Global mRNA Vaccine And Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global mRNA Vaccine And Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries mRNA Vaccine And Therapeutics Market Size 2026-2031 ($ millions)
